Crossref
Chemotherapy-induced peripheral neuropathy: neurophysiological mechanisms, emerging biomarkers, and evidence-based prevention strategies
Oncology in Clinical Practice · 15.01.2026 · 22
DOI: 10.5603/ocp.113058 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology in Clinical Practice, online erschienen am 15.01.2026. Verfasst von Hossam R. Alkashgari.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Alkashgari, H. R. (2026). Chemotherapy-induced peripheral neuropathy: neurophysiological mechanisms, emerging biomarkers, and evidence-based prevention strategies. Oncology in Clinical Practice, 22(0). https://doi.org/10.5603/ocp.113058
Vancouver
Alkashgari HR. Chemotherapy-induced peripheral neuropathy: neurophysiological mechanisms, emerging biomarkers, and evidence-based prevention strategies. Oncology in Clinical Practice. 2026;22(0). doi:10.5603/ocp.113058
BibTeX
@article{Alkashgari2026,
author = {Alkashgari, Hossam R.},
title = {Chemotherapy-induced peripheral neuropathy: neurophysiological mechanisms, emerging biomarkers, and evidence-based prevention strategies},
journal = {Oncology in Clinical Practice},
year = {2026},
volume = {22},
number = {0},
doi = {10.5603/ocp.113058}
}
EUVIMED